Download PDF
TumorDiagnostik & Therapie 2020; 41(08): 513-516
DOI: 10.1055/a-1211-0839
Schwerpunkt Kopf-Hals-Tumoren

Kopf-Hals-Tumoren – Ätiologie und Rolle der HPV

Jens Peter Klussmann
,
Shachi Jenny Sharma
› Further Information
Also available at
    Permissions and Reprints

Die mit Abstand häufigste Form des Kopf-Hals-Malignoms stellt mit ca. 90 % das Plattenepithelkarzinom dar, welches im Wesentlichen mit den Risikofaktoren Tabak- und Alkoholkonsum assoziiert ist. Ein weiterer Risikofaktor ist die Infektion mit dem Hochrisiko (HR)-humanen Papillomavirus (HPV).

Publication History

Article published online:
07 October 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Castellsague X, Alemany L, Quer M. et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst 2016; 108: djv403
    CrossrefPubMedGoogle Scholar
  • 2 Wagner S, Reder H, Sharma SJ. et al. HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment. Urologe A 2018; 57: 1457-1463
    CrossrefPubMedGoogle Scholar
  • 3 Wittekindt C, Wagner S, Klussmann JP. HPV-associated head and neck cancer. The basics of molecular and translational research. HNO 2011; 59: 885-892
    CrossrefPubMedGoogle Scholar
  • 4 Bouvard V, Baan R, Streif K. et al. A review of human carcinogens, Part B: biological agents. Lancet Oncol 2009; 10: 321-322
    CrossrefPubMedGoogle Scholar
  • 5 Olthof NC, Straetmans JMJ, Snoeck R. et al. Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?. Rev Med Virol 2012; 22: 88-105
    CrossrefPubMedGoogle Scholar
  • 6 Wurdemann N, Wager S, Sharma SJ. et al. Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma. Front Oncol 2017; 7: 129
    CrossrefPubMedGoogle Scholar
  • 7 Reuschenbach M, Tinhofer I, Witekindt C. et al. A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany. Cancer Med 2019; 8: 1908-1918
    CrossrefPubMedGoogle Scholar
  • 8 Wittekindt C, Wagner S, Bushnak A. et al. Increasing Incidence rates of Oropharyngeal Squamous Cell Carcinoma in Germany and Significance of Disease Burden Attributed to Human Papillomavirus. Cancer Prev Res 2019; 12: 375-382
    CrossrefPubMedGoogle Scholar
  • 9 Chaturvedi AK, Engels EA, Pfeiffer RM. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301
    CrossrefPubMedGoogle Scholar
  • 10 Tribius S, Hoffmann M. Human papilloma virus infection in head and neck cancer. Dtsch Arztebl Int 2013; 110: 184-190
    PubMedGoogle Scholar
  • 11 Klussmann JP, Wiessenborn SJ, Wieland U. et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?. Med Microbiol Immunol 2003; 192: 129-132
    CrossrefPubMedGoogle Scholar
  • 12 Sharma SJ, Wagner S, Reder HSF. et al. The 8th edition AJCC/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement?. Eur Arch Otorhinolaryngol 2018; 275: 3087-3091
    CrossrefPubMedGoogle Scholar
  • 13 Speel EJ. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Recent Results Cancer Res 2017; 206: 57-72
    CrossrefPubMedGoogle Scholar
  • 14 D'Souza G, McNeel TS, Fakhry C. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Ann Oncol 2017; 28: 3065-3069
    CrossrefPubMedGoogle Scholar
  • 15 Wagner S, Böckmann H, Gattenlöhner S. et al. The innate immune system in oropharyngeal squamous cell carcinoma: Immune modulation by HPV. HNO 2018; 66: 301-307
    CrossrefPubMedGoogle Scholar
  • 16 Wagner S, Sharma SJ, Wuerdemann N. et al. Human Papillomavirus-Related Head and Neck Cancer. Oncol Res Treat 2017; 40: 334-340
    CrossrefPubMedGoogle Scholar
  • 17 Wittekindt C, Wagner S, Sharma SJ. et al. HPV – A different view on Head and Neck Cancer. Laryngorhinootologie 2018; 97 (Suppl. 01) S48-S113
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Olthof NC, Huebbers CU, Kolligs J. et al. Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer 2015; 136: E207-E218
    CrossrefPubMedGoogle Scholar
  • 19 Olthof NC, Speel EJM, Kolligs J. et al. Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 2014; 9: e88718
    CrossrefPubMedGoogle Scholar
  • 20 Nulton TJ, Olex AL, Dozmorov M. et al. Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. Oncotarget 2017; 8: 17684-17699
    CrossrefPubMedGoogle Scholar
  • 21 Mooren JJ, Kremer B, Claessen SMH. et al. Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV16 integration and indicates a favorable prognosis. Int J Cancer 2013; 132: 1781-1789
    CrossrefPubMedGoogle Scholar
  • 22 Lace MJ, Anson JR, Klussmann JP. et al. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J Virol 2011; 85: 1645-1654
    CrossrefPubMedGoogle Scholar
  • 23 Wagner S, Wuerdemann N, Huebbers C. et al. HPV-associated head and neck cancer: mutational signature and genomic aberrations]. HNO 2015; 63: 758-767
    CrossrefPubMedGoogle Scholar
  • 24 Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517: 576-582
    CrossrefPubMedGoogle Scholar
  • 25 Klussmann JP, Mooren JJ, Lehnen M. et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009; 15: 1779-1786
    CrossrefPubMedGoogle Scholar
  • 26 Smeets SJ, Braakhuis BJM, Abba S. et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 2006; 25: 2558-2564
    CrossrefPubMedGoogle Scholar
  • 27 Wagner S, Wittekindt C, Reuschenbach M. et al. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma. Int J Cancer 2016; 138: 2263-2273
    CrossrefPubMedGoogle Scholar
  • 28 Reuschenbach M, Huebbers C, Prigge ES. et al. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers. Cancer 2015; 121: 1966-1976
    CrossrefPubMedGoogle Scholar
  • 29 Chaiwongkot A, Vinokurova S, Pientong C. et al. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer 2013; 132: 2087-2094
    CrossrefPubMedGoogle Scholar
  • 30 Kostareli E, Holzinger D, Bogatyrova O. et al. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J Clin Invest 2013; 123: 2488-2501
    CrossrefPubMedGoogle Scholar
  • 31 Emmett S, Whiteman DC, Panizza BJ. et al. An Update on Cellular MicroRNA Expression in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma. Oncology 2018; 95: 193-201
    CrossrefPubMedGoogle Scholar
  • 32 Miller DL, Davis JW, Taylor KH. et al. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas. Am J Pathol 2015; 185: 679-692
    CrossrefPubMedGoogle Scholar